Sanofi epilepsy drug linked to over 4,000 child deformities

0

French regulator says women taking the valproate were four times more likely to give birth to babies with malformities

The epilepsy medication valproate is responsible for “severe malformations” in up to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by health authorities.

Women who took the drug during pregnancy to treat epilepsy were four times more likely to give birth to babies with congenital malformations, said the report, jointly issued by the medicines regulator ANSM and the national health insurance administration.

Related: Epilepsy patients turning to medicinal cannabis, survey shows

Related: Could Pfizer’s record fine for unfair prices change the industry’s practices?

Continue reading…      

Share.

About Author

Comments are closed.